| Literature DB >> 28577555 |
Emilia Luca1, Laura Fici1,2, Anna Ronchi3, Ferdinando Marandino4, Esther Diana Rossi1, Maria Emiliana Caristo1, Pasqualino Malandrino5, Marco Russo5, Alfredo Pontecorvi1, Riccardo Vigneri6,7, Fabiola Moretti8,9.
Abstract
BACKGROUND: Epidemiologic data in volcanic areas suggest that environmental factors might be involved in the increase of thyroid cancer (TC) incidence. Recent reports indicate that several heavy metals and metalloids are increased in volcanic areas. This study aims to evaluate the combined effect of three of these elements Boron (B), Cadmium (Cd), and Molybdenum (Mo) - all increased in the volcanic area of Mt. Etna, in Italy - on thyroid tumorigenesis in the rat.Entities:
Keywords: Boron; Cadmium; Heavy metals; Metalloids; Molybdenum; Thyroid; Thyroid cancer; Thyroid nodules; Volcanic area
Mesh:
Substances:
Year: 2017 PMID: 28577555 PMCID: PMC5455132 DOI: 10.1186/s13046-017-0543-z
Source DB: PubMed Journal: J Exp Clin Cancer Res ISSN: 0392-9078
Elements, compounds, and concentration [C] used for animal treatment
| Element (MWa) | [C] of element in urine samples | [C] of element in drinking water of Group B | Compound used in drinking water (MW) | [C] of compound in drinking water of Group B | LD50 compound in rat |
|---|---|---|---|---|---|
| B (10.81) | 800 μg/L (74 μM) | 1600 μg/L (148 μM) | Boric Acid (61.83) | 9.14 mg/L | 270–675 mg |
| Cd (112.41) | 0.2 μg/L (1.8 nM) | 0.4 μg/L (3.6 nM) | Cadmium Chloride (183.32) | 0.66 μg/L | 8.8–22 mg |
| Mo (95.96) | 50 μg/L (0.52 μM) | 100 μg/L (1.04 μM) | Ammonium heptamolybdate tetrahydrate (1235.86) | 1.286 mg/L | 33–83 mg |
a MW molecular weight
Instrument Operating Parameters for DRC-ICP-MS analysis
| RF power | 1250 W | |
|---|---|---|
| Plasma argon | 15 L/min | |
| Nebulizer flow | 1.0 L/min | |
| Auxiliary flow | 1.3 L/min | |
| Sample flow rate | 1 L/min | |
| Nebulizer | Mainhart | |
| Interface cones | Platinum | |
| Scan mode | Peak hopping | |
| Resolution | Normal | |
| Sweeps/readings | 20 | |
| Readings/replicates | 3 | |
| Number of replicates | 5 | |
| Sample time | 1 min 39 s | |
| Sample read delay | 50 s | |
| Autosampler wash delay | 45 s | |
| Calibration mode | External calibration | |
| Calibration standard | 0.1, 0.5, 1, 2, 5, 10, 20 μg/L | |
| Curve fit | Linear through zero | |
| DRC parameters | DRC Vented (standard mode) | DCR Pressurized (enhanced mode) |
| Cell q parameter | 0.25 | 0.65 |
| Cell a parameter | 0 | 0 |
| Cell gas | No gas | NH3 at 0.5 mL/min |
Fig. 1Metal supplementation does not alter animal growth. Weight curves of control group A (dotted blue line) and metal-treated group B (dotted red line). Continued lines represent the linear interpolation of experimental values from group A (blue line) and metal-treated group B (red line)
Fig. 2Supplemented metals accumulate in the urine samples of experimental rats. a Urine values of B, Cd, and Mo in the control group A (NT) and metal-treated group B after 1, 5 and 10 months of treatment. b Urine values of iodine in the control group A (NT) and metal-treated group B after 1, 5 and 10 months of treatment. Error bars represent Mean ± SD (n = 5)
Fig. 3Representative picture of hematoxyline-eosin staining of thyroid specimens from a normal untreated rat a, a Group A rat treated with the goitrogenic diet b and g, and Group B rats treated with the goitrogenic diet and B, Cd and Mo c-f and h. Arrows indicate thyroid features as reported in Table 4
Concentrations of chemical elements in rat thyroid samples
| Groups | DNA | I Iodine | B Boron | Mo Molybdenum | Cd Cadmium | |||
|---|---|---|---|---|---|---|---|---|
| μg/ga | ug/DNA | μg/g | ug/DNA | μg/g | ug/DNA | μg/g | ||
| TA1 | 0.974 | 2.378 | 2.440 | 0.181 | 0.186 | 0.045 | 0.046 | <0.01 |
| TA2 | 0.440 | 1.039 | 2.361 | 0.342 | 0.778 | 0.036 | 0.083 | <0.01 |
| TA3 | 0.414 | 1.386 | 3.348 | 1.025 | 2.476 | 0.036 | 0.086 | < 0.01 |
| TA4 | 0.178 | 0.479 | 2.692 | 0.122 | 0.686 | 0.044 | 0.245 | < 0.01 |
| TA5 | 0.217 | 0.716 | 3.294 | 0.174 | 0.801 | 0.052 | 0.241 | < 0.01 |
| TA6 | 0.253 | 0.943 | 3.733 | 0.159 | 0.630 | 0.036 | 0.142 | < 0.01 |
| MEAN | 1.109 | 2.978 | 0.334 | 0.926 | 0.041 | 0.140 | ||
| SD | 0.742 | 0.468 | 0.376 | 0.870 | 0.007 | 0.095 | ||
| TB1 | 0.322 | 0.441 | 1.368 | 0.572 | 1.774 | 0.024 | 0.074 | < 0.01 |
| TB2 | 0.451 | 0.312 | 0.691 | 0.678 | 1.502 | 0.035 | 0.076 | < 0.01 |
| TB3 | 0.568 | 0.458 | 0.806 | 0.161 | 0.283 | 0.050 | 0.089 | < 0.01 |
| TB5 | 0.340 | 0.889 | 2.611 | < 0.01 | 0.046 | 0.136 | < 0.01 | |
| TB6 | 0.549 | 0.762 | 1.389 | 0.081 | 0.148 | 0.043 | 0.078 | < 0.01 |
| MEAN | 0.572 | 1.373 | 0.373 | 0.915 | 0.040 | 0.091 | ||
| SD | 0.652 | 0.761 | 0.296 | 0.830 | 0.010 | 0.0256 | ||
| P | 0.134229 | 0.009976 | 0.854547 | 0.9994165 | 0.74384 | 0.222808 | ||
aμg/g = μg of chemical/g of thyroid tissue
Cumulative morphological features of the thyroid in group A and B
| Features | Groupsa | ||
|---|---|---|---|
| A | B | ||
| 5 Months | |||
| Follicles | |||
| - Disomogeneity (mild) | 0% | 40% (2/5) | |
| - Nuclear clearing | 0% | 40% (2/5) | |
| - Papillary structures | 0% | 0% | |
| Vascular congestion (mild) | 100% (5/5) | 100% (5/5) | |
| 10 Months | |||
| Follicles | |||
| - Disomogeneity (mild) | 17% (1/6) | 0% | |
| • (moderate) | 83% (5/6) | 50% (5/10) | |
| • (severe) | 0% | 50% (5/10) | |
| - Nuclear clearing (mild) | 17% (1/6) | 30% (3/10) | |
| • (moderate) | 83% (5/6) | 30% (3/10) | |
| • (severe) | 0% | 40% (4/10) | |
| - Papillary structures (mild) | 17% (1/6) | 10% (1/10) | |
| • (moderate) | 0% | 50% (5/10) | |
| • (severe) | 0% | 40% (4/10) | |
| Vascular congestion (mild) | 0% | 0% | |
| • (moderate) | 83% (5/6) | 50% (5/10) | |
| • (severe) | 17% (1/6) | 50% (5/10) | |
anumber of affected/total animals
Mild = present in less than 10% of the examined area, Moderate = present in 10–30% of the examined area, Severe = present in more than 30% of the examined area